Abstract:This study presents an innovative research model utilizing big data science and protein structure prediction AI software. An unprecedented amount of SARS-CoV-2 data has been accumulated compared with previous infectious diseases, enabling insights into its evolutionary process and more thorough analyses. We identified amino acid substitutions ranging from hydrophilic to hydrophobic, or positively charged amino acids in the RBM region. An increased frequency of amino acid substitutions to lysine (K) and arginine (R) was detected in Variants of Concern (VOCs) and viral sequencing data. As the virus evolved to Omicron, commonly occurring mutations became fixed components of the new viral sequence. Furthermore, in specific positions, only one type of amino acid substitution and a notable absence of mutations at D467 was detected across viral sequences in VOCs. The binding affinity with the ACE2 receptor increased for later lineages. We developed APESS, a mathematical model evaluating infectivity based on biochemical and mutational properties calculated from a protein prediction of AlphaFold. We validated discoveries of features found through APESS. Infectivity was evaluated in silico using real-world viral sequences and in vitro viral entry assays. Using Machine Learning, we predicted mutations that had the potential to become more prominent. APESS and characteristics we discovered are featured in AIVE, a web-based system, accessible at https://ai-ve.org. AIVE provides an infectivity measurement of mutations entered by users which is available on fast APESS calculations and visualization of results without GPU installation. We established a clear link between specific viral properties and increased infectivity. Comprehensive analysis and specialized AIVE reporting enhance our understanding of SARS-CoV-2 and enable more accurate predictions of infectivity.

iDVEIP: A computer‐aided approach for the prediction of viral entry inhibitory peptides

Virus-Derived Peptides for Clinical Applications

Current Development of Data Resources and Bioinformatics Tools for Anticoronavirus Peptide

A two-stage computational framework for identifying antiviral peptides and their functional types based on contrastive learning and multi-feature fusion strategy

AIVE: accurate predictions of SARS-CoV-2 infectivity from comprehensive analysis

DeepAVP: A Dual-Channel Deep Neural Network for Identifying Variable-Length Antiviral Peptides

Predicting viral proteins that evade the innate immune system: a machine learning-based immunoinformatics tool

ACVPICPred: inhibitory activity prediction of anti-coronavirus peptides based on artificial neural network

IPEV: identification of prokaryotic and eukaryotic virus-derived sequences in virome using deep learning

AI4AVP: an antiviral peptides predictor in deep learning approach with generative adversarial network data augmentation

ENNAVIA is a novel method which employs neural networks for antiviral and anti-coronavirus activity prediction for therapeutic peptides

FEOpti-ACVP: identification of novel anti-coronavirus peptide sequences based on feature engineering and optimization

A framework for predicting variable-length epitopes of human-adapted viruses using machine learning methods

HybAVPnet: a Novel Hybrid Network Architecture for Antiviral Peptides Prediction

iAVPs-ResBi: Identifying antiviral peptides by using deep residual network and bidirectional gated recurrent unit

Identification of Peptide Inhibitors of Enveloped Viruses Using Support Vector Machine

Recent Advances in Machine Learning-Based Models for Prediction of Antiviral Peptides

ACEiPP: A Deep Learning-Based Framework to Predict Angiotensin-Converting Enzyme (ACE)-Inhibitory Peptides Using High-Efficiency Amino Acid Descriptors

Emvirus: An embedding-based neural framework for human-virus protein-protein interactions prediction

Innovative Alignment-Based Method for Antiviral Peptide Prediction